Printer Friendly

Browse Drug approval topic

 

Articles

1-300 out of 500 article(s) nextnext page
Title Author Type Date Words
Even The Score Marks 17th Viagra Anniversary with Release of New Letter from Members of Congress to FDA Calling for Equity in Sexual Health. Mar 26, 2015 1048
EYLEA (aflibercept) Injection Receives FDA Approval for the Treatment of Diabetic Retinopathy in Patients with Diabetic Macular Edema (DME). Mar 25, 2015 2313
AdverseEvents Sets New Standard For Drug Decision Making With Launch Of RxCost(TM). Mar 24, 2015 751
Health Ministry forms national database on pharmaceutical drugs. Mar 20, 2015 265
State Council Approves Amendments to Drugs, Psychotropic Substances Law. Mar 18, 2015 150
ASBM Educates Pharmacists on Biosimilars as FDA Makes First Approval. Mar 16, 2015 674
Actavis Receives FDA Approval for VIIBRYD (vilazodone HCl) 20mg Once Daily as a Therapeutic Dose. Mar 16, 2015 2157
Pharmaceutical products. Mar 14, 2015 106
Actavis Receives FDA Approval of SAPHRIS for Pediatric Patients (age 10-17) for Acute Treatment of Manic or Mixed Episodes of Bipolar I Disorder. Mar 13, 2015 2161
Blood cancer drug to be available on NHS. Mar 12, 2015 211
Endure Desensitizing Sexual Enhancement Spray Is FDA Approved. Mar 12, 2015 504
Mylan Launches Generic Antabuse Tablets. Mar 11, 2015 469
Mylan Launches Generic Subutex Sublingual Tablets. Mar 11, 2015 367
Neuroblastoma Expert John Maris, M.D., Available to Discuss FDA Approval of Unituxin, the Third FDA-Approved Drug Ever for Children with Cancer. Mar 11, 2015 394
NewSkin Laser Center Offering Restylane[R] Silk - First and Only FDA Approved Filler Indicated for Lip Enhancement and Treatment of Perioral Lines. Mar 10, 2015 348
Diclegis for Morning Sickness Now Available Through Aetna's National Coverage Policy. Medical condition overview Mar 10, 2015 1433
FDA Approves Unituxin(TM) (dinutuximab) for the Treatment of Pediatric High-Risk Neuroblastoma. Mar 10, 2015 2472
United Therapeutics Receives a Rare Pediatric Disease Priority Review Voucher following the Approval of Unituxin(TM) for Pediatric High-Risk Neuroblastoma. Mar 10, 2015 1780
United States : Astellas Receives FDA Approval for CRESEMBA (isavuconazonium sulfate) for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis. Mar 10, 2015 663
Legal-Bay Lawsuit Settlement Funding Reports Bayer and Johnson & Johnson to Pursue Further FDA Approvals for Xarelto while Cases against the Drug are Consolidated into Multidistrict Litigation. Mar 9, 2015 727
Endure Desensitizing Sexual Enhancement Spray Is FDA Approved. Mar 9, 2015 422
United States : FDA approves first type of new generic. Mar 9, 2015 106
United States : US FDA made fast clearance to the lung cancer drug of BMS. Mar 7, 2015 311
United States : FDA approves first biosimilar product Zarxio. Mar 7, 2015 410
United States : FDA approves new antifungal drug Cresemba. Mar 7, 2015 413
Prime Therapeutics welcomes FDA's approval of first biosimilar in U.S., but says more clarity is needed. Mar 6, 2015 790
Astellas Receives FDA Approval for CRESEMBA (isavuconazonium sulfate) for the Treatment of Invasive Aspergillosis and Invasive Mucormycosis. Mar 6, 2015 1524
United States : Elepsia XR Levetiracetam extended-release tablets gets nod from FDA. Mar 5, 2015 117
United States : FDA expands approved use of Opdivo to treat lung cancer. Mar 5, 2015 438
Veloxis Pharmaceuticals publishes Annual Report 2014. Mar 3, 2015 7079
Ireland,United States : USFDA approval for ACTAVIS and MEDICINES360 for pregnancy prevention drug Liletta. Mar 3, 2015 263
Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults. Mar 2, 2015 1150
Shire Submits Application to the U.S. FDA for Approval of Lifitegrast for Treatment of Dry Eye Disease in Adults. Mar 2, 2015 1155
Actavis Receives Approval from the European Commission for XYDALBA(TM) (dalbavancin). Mar 2, 2015 1080
FDA commissioner Dr. Margaret Hamburg resigns. Mar 1, 2015 133
AbbVie's HUMIRA (Adalimumab) Receives Positive CHMP Opinion to Treat Children and Adolescents With Severe Chronic Plaque Psoriasis. Feb 27, 2015 1242
Ireland : ACTAVIS wants FDA approval to market generic ulcerative colitis drug. Feb 27, 2015 164
The Leukemia & Lymphoma Society Applauds Therapy Advances for Myeloma Patients. Feb 26, 2015 817
AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting. Feb 26, 2015 1951
United States : FDA approves new antibacterial drug Avycaz. Feb 26, 2015 426
Xarelto Lawsuit News: Bayer and Johnson & Johnson Pursue Additional FDA Approvals for Xarelto while Cases against the Blood Thinner are Consolidated into Multidistrict Litigation, Says Lawsuitsettlementnews.com. Feb 25, 2015 667
Actavis Receives U.S. FDA Approval for AVYCAZ(TM) (CEFTAZIDIME-AVIBACTAM). Feb 25, 2015 2389
United States : FDA approves Farydak for treatment of multiple myeloma. Feb 24, 2015 450
Actavis Confirms Generic Uceris Patent Challenge. Feb 24, 2015 867
Novartis receives FDA approval of Farydak, the first HDAC inhibitor for patients with multiple myeloma. Feb 23, 2015 2732
Azzi: NSSF will only cover approved generic drugs. Feb 21, 2015 392
United States : US FDA extends approval on its multiple myeloma blockbuster REVLIMID. Feb 20, 2015 117
Actavis Receives Final Approval for Generic Version of Subutex. Feb 20, 2015 712
Flu Treatment Sponsored By DoD's Medical Countermeasure Systems Takes Major Step Forward In Clinical Trials. Feb 19, 2015 844
United States : EISAI INC secures FDA approval for its supplemental New Drug Application. Feb 16, 2015 172
Switzerland : Novartis heart failure medicine LCZ696 granted FDA priority review. Feb 14, 2015 406
United States : FDA approves Lenvima for a type of thyroid cancer. Feb 14, 2015 428
Supply of Pharmaceutical products. Feb 14, 2015 109
Supply of Pharmaceutical products. Feb 14, 2015 105
Eisai Announces FDA Approval of BANZEL (rufinamide) for Adjunctive Treatment of Seizures Associated with Lennox-Gastaut Syndrome in Pediatric Patients Ages 1-4. Feb 13, 2015 1318
FDA Approves Eisai's LENVIMA(TM) (lenvatinib) for the Treatment of Patients with Locally Recurrent or Metastatic, Progressive, Radioactive Iodine-Refractory Differentiated Thyroid Cancer. Feb 13, 2015 2610
Actavis Launches Generic Pulmicort RESPULES. Feb 13, 2015 773
Multimedia Assets Now Available: FDA Approves Eisai's LENVIMA(TM) (lenvatinib) for the Treatment of Patients with Locally Recurrent or Metastatic, Progressive, Radioactive Iodine-Refractory Differentiated Thyroid Cancer. Feb 13, 2015 2642
Amgen Announces FDA Advisory Committees To Review Talimogene Laherparepvec For The Treatment Of Patients With Metastatic Melanoma. Feb 11, 2015 2024
Switzerland : FDA approves Roche's Lucentis (ranibizumab injection) for treatment of diabetic retinopathy in people with diabetic macular edema. Feb 10, 2015 345
United States : FDA approves Lucentis to treat diabetic retinopathy in patients with diabetic macular edema. Feb 10, 2015 476
CASI Pharmaceuticals Announces Receipt Of Final Minutes From FDA Meeting Regarding Clinical And Regulatory Path Of ENMD-2076 For The Treatment Of Patients With Fibrolamellar Carcinoma (FLC). Feb 9, 2015 1314
European Commission Approves Additional Indication for VELCADE (bortezomib) in Mantle Cell Lymphoma. Feb 6, 2015 2033
New FDA Approved Filler Restylane Silk Available at Dr. Anne White's Cosmetic Surgery practice Carolina Laser and Cosmetic Center in Winston Salem. Feb 5, 2015 568
Anti-Epilepsy Drug Preserves Brain Function after Stroke. Feb 5, 2015 692
Germany,United States : FDA approves AESICA for German bulk manufacture and packaging sites. Feb 4, 2015 161
Rich Pharmaceuticals Announces Completion of the Manufacture of RP-323 Study Drug in Connection with Obtaining FDA's Final Approval of The Investigational New Drug (IND) Application For The Treatment of Acute Myelocytic Leukemia. Feb 4, 2015 756
Switzerland : Alcon receives FDA approval of Pazeo(TM) Solution for ocular allergy itch relief. Feb 3, 2015 416
THC and Opiates: "Entourage Effect" of Prismic's IP-Protected Palmitoylethanolamide Drives New Prescription Drug Strategy. Feb 3, 2015 469
Theravance Biopharma, Inc. and Mylan Partner to Develop and Commercialize a Novel LAMA Compound, TD-4208, for COPD. Feb 2, 2015 2514
Lpath Submits Investigational New Drug Application for Lpathomab for Neuropathic Pain. Feb 2, 2015 848
U.S. FDA approves first-in-class Glyxambi (empagliflozin/linagliptin) tablets for adults with type 2 diabetes. Feb 2, 2015 3117
FDA Approves New Dosing Option for CSL Behring's Hizentra. Feb 2, 2015 1382
TOS: FDA Approves New Drug for Binge Eating Disorder (BED). Feb 2, 2015 588
CM-24 RECEIVES FDA APPROVAL FOR PHASE 1 TRIAL. Feb 1, 2015 516
New law to expedite sunscreen approvals. Krisberg, Kim Feb 1, 2015 147
FDA panel rejects oral desmopressin for nocturia. Mechcatie, Elizabeth Feb 1, 2015 977
FDA approves IV antibacterial for complicated UTIs. Mechcatie, Elizabeth Feb 1, 2015 319
PL DEVELOPMENTS RECEIVES ITS FIRST ANDA APPROVAL. Feb 1, 2015 211
The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Patients with Waldenstrom's Macroglobulinemia. Jan 30, 2015 606
Vyvanse (lisdexamfetamine dimesylate) Capsules (CII) Becomes First and Only Treatment Approved by the FDA for Adults with Moderate to Severe Binge Eating Disorder. Jan 30, 2015 2555
Vyvanse (lisdexamfetamine dimesylate) Capsules (CII) Becomes First and Only Treatment Approved by the FDA for Adults with Moderate to Severe Binge Eating Disorder. Jan 30, 2015 2560
United States : U.S. FDA Approves IMBRUVICA(ibrutinib) for the Treatment of Waldenstrom's Macroglobulinemia: First FDA-Approved Therapy for This Disease. Jan 30, 2015 450
United States : FDA expands approved use of Imbruvica for rare form of non-Hodgkin lymphoma. Jan 30, 2015 432
Galderma Launches Restylane Silk - First and Only FDA Approved Filler Indicated for Lip Enhancement and Treatment of Perioral Lines. Jan 29, 2015 1434
U.S. FDA Approves IMBRUVICA (ibrutinib) for Treatment of Waldenstrom's macroglobulinemia (WM). Jan 29, 2015 2959
U.S. FDA Approves IMBRUVICA (ibrutinib) for the Treatment of Waldenstrom's Macroglobulinemia: First FDA-Approved Therapy for This Disease. Jan 29, 2015 2263
The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Patients with Waldenstrom's Macroglobulinemia. Jan 29, 2015 604
Sweden,United States : FDA approves new strength of Norditropin FlexPro. Jan 29, 2015 151
PMC Analysis: More Than 20 Percent of FDA's 2014 Novel New Drug Approvals are Personalized Medicines. Jan 28, 2015 544
RegeneRx and G-treeBNT Create Joint Venture to Develop RGN-259 in the U.S. Jan 28, 2015 1031
Amgen Submits Applications In The US And Europe For Kyprolis (carfilzomib) For The Treatment Of Relapsed Multiple Myeloma. Jan 27, 2015 2949
United States : BEXSERO VACCINE gets approval from FDA. Jan 27, 2015 102
Impax Receives FDA Approval for a Generic Version of Lamictal Orally Disintegrating Tablets (ODT). Jan 26, 2015 1249
Weight-loss shortcuts: The truth behind the hype. Jan 25, 2015 641
Switzerland : Novartis Bexsero vaccine approved by FDA for the prevention of meningitis B, the leading cause of bacterial meningitis in the US. Jan 24, 2015 432
Switzerland : Novartis drug Jakavi recommended by CHMP for EU approval to treat adults with rare blood cancer polycythemia vera. Jan 24, 2015 412
Ireland : Shire Comments on Press Release from NPS Pharma Regarding FDA Approval of NATPARA (parathyroid hormone). Jan 24, 2015 236
United States : FDA approves Natpara to control low blood calcium levels in patients with hypoparathyroidism. Jan 24, 2015 424
United States : FDA approves a second vaccine to prevent serogroup B meningococcal disease. Jan 24, 2015 455
The National Meningitis Association (NMA) Applauds FDA Approval of Second Vaccine To Protect Against Serogroup B Meningococcal Disease. Jan 23, 2015 621
Novartis Bexsero vaccine approved by FDA for the prevention of meningitis B, the leading cause of bacterial meningitis in the US. Jan 23, 2015 2183
Diclegis for Morning Sickness Now Available Through Texas Fee-For-Service Medicaid Program. Medical condition overview Jan 22, 2015 1330
Astellas Announces FDA Anti-Infective Drugs Advisory Committee Recommends Approval of CRESEMBA (isavuconazonium) for Treatment of Invasive Aspergillosis and Mucormycosis. Jan 22, 2015 664
Switzerland : Novartis announces FDA approval for first IL-17A antagonist Cosentyx(TM) (secukinumab) for moderate-to-severe plaque psoriasis patients. Jan 22, 2015 435
United States : FDA approves new psoriasis drug Cosentyx. Jan 22, 2015 456
Ventana seeks FDA premarket approval for ALK IHC companion diagnostic to benefit lung cancer patients. Jan 21, 2015 776
Ventana seeks FDA premarket approval for ALK IHC companion diagnostic to benefit lung cancer patients. Jan 21, 2015 804
United States : Baxter Receives FDA Approval for PHOXILLUM Solution for Electrolyte Management During Continuous Renal Replacement Therapy. Jan 21, 2015 344
Belgium : Boehringer Ingelheim wins EC approval for drug to treat rare lung disease. Jan 20, 2015 167
United States : FDA Grants Priority Review for Three-Month Paliperidone Palmitate for the Treatment of Schizophrenia. Jan 20, 2015 426
FDA Grants Priority Review for Three-Month Paliperidone Palmitate for the Treatment of Schizophrenia. Jan 19, 2015 2435
European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets) for the Treatment of Chronic Hepatitis C. Jan 16, 2015 2161
European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA (dasabuvir tablets) for the Treatment of Chronic Hepatitis C. Jan 16, 2015 2140
AbbVie Announces U.S. FDA Approval of DUOPA(TM) (carbidopa and levodopa) Enteral Suspension for the Treatment of Motor Fluctuations in Patients with Advanced Parkinson's Disease. Jan 16, 2015 1931
Hemlock extra large clips hemlock extra large clips, us fda approved quality, each set having 14 strips of 6 clips each. Jan 16, 2015 218
Hemolok extra large 5 mm endo applier 32.5cm, 5 mm diameter hemolok extra large 5 mm endo applier 32.5cm, 5 mm diameter us fda approved quality, one piece. Jan 16, 2015 227
Hemlock large clips, hemlock large clips, us fda approved quality, each set having 14 strips of 6 clips each. Jan 16, 2015 216
Hemo lok ml endo remover for l/xl us fda approved quality. Jan 16, 2015 223
United Kingdom : European Commission approves new rural fuel tax cut. Jan 16, 2015 480
Mylan Launches Generic Epivir-HBV Tablets. Jan 15, 2015 402
Veloxis Confirms Receipt of U.S. Food and Drug Administration Decision. Jan 13, 2015 554
Drugs alone can't fight diabetes. Jan 12, 2015 1176
AbbVie Announces U.S. FDA Approval of DUOPA(TM) (carbidopa and levodopa) Enteral Suspension for the Treatment of Motor Fluctuations in Patients with Advanced Parkinson's Disease. Jan 12, 2015 1879
Japan : U.S. FDA Approves Daiichi Sankyo's Once-Daily SAVAYSA(edoxaban) Tablets for Reduction of Stroke Risk in Non-Valvular Atrial Fibrillation and for the Treatment of Venous Thromboembolism. Jan 9, 2015 458
United States : FDA approves anti-clotting drug Savaysa. Jan 9, 2015 481
Impax Pharmaceuticals Announce FDA Approval of RYTARY(TM) (Carbidopa and Levodopa) Extended-Release Capsules for the Treatment of Parkinson's disease. Jan 8, 2015 2604
PCMA Statement on the FDA Advisory Committee's Vote to Approve the First U.S. Biosimilar. Jan 8, 2015 354
U.S. FDA Approves Daiichi Sankyo's Once-Daily SAVAYSA(TM) (edoxaban) Tablets for Reduction of Stroke Risk in Non-Valvular Atrial Fibrillation and for the Treatment of Venous Thromboembolism. Jan 8, 2015 4096
Bellafill Receives FDA Approval For Treatment Of Acne Scars. Jan 6, 2015 1209
Mylan Launches Generic Diovan Tablets. Jan 5, 2015 425
United States : NAMZARIC gets FDA approval. Jan 2, 2015 184
FDA APPROVES TWO HIGHER DOSAGE STRENGTHS OF ZUBSOLV. Jan 1, 2015 368
Hospira Receives U.S. FDA Approval of Proprietary Analgesic Dyloject(TM)(diclofenac sodium) Injection. Dec 30, 2014 1493
United States : FDA approval for Namzaric to treat dementia obtained by Actavis and Adamas. Dec 29, 2014 289
United States : US FDA approval for Epivir tabs obtained by Lupin. Dec 29, 2014 118
Providing of Pharmaceutical products. Dec 27, 2014 530
Providing of Pharmaceutical products. Dec 27, 2014 522
United States : FDA Approval Of Namzaric in dementia declared by Actavis and Adamas. Dec 26, 2014 131
United States : FDA approval secured by New drug combo to treat UTIs, intra-abdominal infections. Dec 26, 2014 129
Novo Nordisk receives FDA approval for Saxenda (liraglutide [rDNA origin] injection) for chronic weight management. Dec 24, 2014 2372
United States : FDA approves new flu drug from DURHAM. Dec 24, 2014 249
United States : BIOCRYST gets FDA approval for first intravenous flu drug. Dec 24, 2014 177
United States : FDA approves weight-management drug Saxenda. Dec 24, 2014 459
Actavis and Adamas Announce FDA Approval of Namzaric(TM), a Fixed-Dose Combination of Memantine Extended-Release and Donepezil Hydrochloride. Dec 24, 2014 1717
Personalized Cancer Vaccine Moves to Phase IIb Trial at Leading U.S. Cancer Hospitals. Dec 23, 2014 696
Taiho Oncology Completes Submission of TAS-102 New Drug Application to the US Food and Drug Administration for the Treatment of Refractory Metastatic Colorectal Cancer. Dec 22, 2014 1056
United States : FDA approves Viekira Pak to treat hepatitis C. Dec 20, 2014 458
United States : FDA approves new antibacterial drug Zerbaxa. Dec 20, 2014 414
AbbVie Receives U.S. FDA Approval of VIEKIRA PAK(TM) (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for the Treatment of Chronic Genotype 1 Hepatitis C. Dec 19, 2014 2442
AbbVie Receives U.S. FDA Approval of VIEKIRA PAK(TM) (Ombitasvir/Paritaprevir/Ritonavir Tablets; Dasabuvir Tablets) for the Treatment of Chronic Genotype 1 Hepatitis C. Dec 19, 2014 2461
Jazz Pharmaceuticals Receives FDA Approval For Intravenous Administration Of Erwinaze (asparaginase Erwinia chrysanthemi). Dec 19, 2014 1131
Jazz Pharmaceuticals Receives FDA Approval For Intravenous Administration Of Erwinaze (asparaginase Erwinia chrysanthemi). Dec 19, 2014 1102
Switzerland : Novartis gains FDA approval for Signifor LAR to treat patients with acromegaly, a rare and life-threatening hormonal disorder. Dec 17, 2014 440
Lilly's CYRAMZA (ramucirumab) Receives Third FDA Approval. Dec 16, 2014 4306
Veloxis announces that it has filed an action against the Food and Drug Administration, seeking an order requiring FDA to grant final approval to Envarsus XR. Dec 16, 2014 464
Novartis gains FDA approval for Signifor LAR to treat patients with acromegaly, a rare and life-threatening hormonal disorder. Dec 16, 2014 3055
CSL Behring Submits Biologics License Application for FDA Approval of Recombinant Fusion Protein Linking Coagulation Factor IX with Recombinant Albumin (rIX-FP) for Hemophilia B Patients. Dec 16, 2014 987
United States : FDA expands approved use of Cyramza to treat aggressive non-small cell lung cancer. Dec 13, 2014 457
United States : Medtronic Receives FDA Approval and Launches Two New Cardiac Resynchronization Therapy Quadripolar Leads. Dec 12, 2014 399
TWi Biotechnology Receives Approval of Protocol for Its Drug AC-201 Controlled-Release Tablet, Phase II Clinical Trial in Both the United States and Taiwan. Dec 12, 2014 676
To Mitigate Risk of Infusion Reactions with Krystexxa, Serum Urate Should be Used as a Predictive Marker. Dec 12, 2014 1429
United States : FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV. Dec 11, 2014 494
Mylan Launches First Generic Version of Orapred ODT. Dec 11, 2014 426
Mylan Launches Generic Robaxin Injection. Dec 11, 2014 415
MD Anderson officials react to FDA Approval of Gardasil 9 for the prevention of certain cancers. Dec 11, 2014 652
RELIEF AS LEUKAEMIA DRUG GETS APPROVED; Therapy could cut cancer death toll by 59 per cent, trials show. Dec 9, 2014 309
Daiichi Sankyo Launches New Formulation of LIXIANA 60 mg Tablets (edoxaban) in Japan. Dec 8, 2014 2193
Daiichi Sankyo Launches New Formulation of LIXIANA 60 mg Tablets (edoxaban) in Japan. Dec 8, 2014 2233
FDA Approves Amgen's XGEVA (Denosumab) For The Treatment Of Hypercalcemia Of Malignancy Refractory To Bisphosphonate Therapy. Dec 8, 2014 2705
Otsuka: U.S. FDA Approves Labeling Update of Abilify Maintena (Aripiprazole). Dec 8, 2014 128
New Trial Initiated Evaluating Amgen's Talimogene Laherparepvec In Combination With Merck's Anti-PD-1 Therapy KEYTRUDA (Pembrolizumab) For Advanced Melanoma. Dec 8, 2014 2463
United States : FDA approves Jakafi to treat patients with a chronic type of bone marrow disease. Dec 5, 2014 452
Anti-Infective Advisory Committee Recommends Approval Of Actavis' Ceftazidime-Avibactam. Dec 5, 2014 1179
United States : FDA Approves BLINCYTO (blinatumomab) Immunotherapy for the Treatment of Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia. Dec 4, 2014 197
FDA Approves BLINCYTO(TM) (Blinatumomab) Immunotherapy for the Treatment of Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia. Dec 3, 2014 3471
The Leukemia & Lymphoma Society Applauds FDA Approval of Blinatumomab To Treat Patients with Acute Lymphoblastic Leukemia. Dec 3, 2014 608
Diclegis for Morning Sickness Now Available Through Tennessee's Fee-For-Service Medicaid Program. Medical condition overview Dec 2, 2014 1337
Perrigo Announces FDA Approval And Launch Of The Generic Version Of Pennsaid 1.5% w/w. Dec 2, 2014 773
Synageva BioPharma Completes Rolling Submission Of Biologics License Application To The FDA For Sebelipase Alfa And Submits Marketing Authorization Application To European Medicines Agency. Dec 2, 2014 1118
United States : HeartFlow FFR-CT software wins marketing approval from FDA. Dec 2, 2014 229
Telesta Therapeutics Announces Key Clinical & Corporate Updates. Dec 1, 2014 864
Sunscreen act reaches president's desk. Dec 1, 2014 129
Whistle blower protections and the false claims Act. Bondi, Pam Dec 1, 2014 623
European Commission Approves Trulicity (dulaglutide) Solution for Injection, Lilly's Once-Weekly, Ready-to-Use Type 2 Diabetes Treatment. Nov 25, 2014 1101
Valeant Pharmaceuticals Announces FDA Approval Of ONEXTON(TM) Gel For The Treatment Of Acne Vulgaris. Nov 25, 2014 962
Switzerland : Novartis drug Signifor approved in EU, marking an advance for patients with inadequately controlled acromegaly. Nov 25, 2014 428
IGI Laboratories, Inc. Announces ANDA Submission. Nov 24, 2014 559
United States : MERRIMACK PHARMACEUTICALS begins application of approval of cancer drug. Nov 24, 2014 182
United States : FDA approves extended-release, single-entity hydrocodone product with abuse-deterrent properties. Nov 21, 2014 436
Purdue Pharma L.P. Receives FDA Approval for Hysingla(TM) ER (hydrocodone bitartrate) Extended-Release Tablets CII, A Once-Daily Opioid Analgesic Formulated with Abuse-Deterrent Properties. Nov 20, 2014 2779
JCI Pharmaceutical Co., Ltd. Receives Approval from US FDA for Colloidal Iodine Formulation. Nov 20, 2014 913
JCI Pharmaceutical Co., Ltd. Receives Approval from US FDA for Colloidal Iodine Formulation. Nov 20, 2014 909
Project Innovation Launches the Cancer Medicines Interactive Timeline to Highlight the Need for Continued Cancer Innovation in the U.S. Chronology Nov 20, 2014 1625
Janssen Submits New Drug Application to U.S. FDA for Three-Month Paliperidone Palmitate. Nov 19, 2014 2431
MPs approve bill allowing to open drug market of Kyrgyzstan for cheap generics. Nov 18, 2014 170
Robbins Arroyo LLP Is Investigating the Officers and Directors of Sarepta Therapeutics, Inc. (SRPT) on Behalf of Shareholders. Nov 18, 2014 540
White Paper: How FDA Can Increase Competition Among Brand, Generic and Specialty Medications. Nov 17, 2014 526
United States : US FDA approval gained by Par Pharmas vasopressin injection. Nov 15, 2014 194
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Sarepta Therapeutics, Inc. (SRPT) To Contact The Firm. Nov 14, 2014 440
United States : FDA grants approval to PAR PHARMACEUTICAL for new drug application. Nov 14, 2014 143
United States : U.S. FDA Approves Supplemental New Drug Applications for Once-Monthly Long-Acting Therapy INVEGA SUSTENNA (paliperidone palmitate) for the Treatment of Schizoaffective Disorder. Nov 14, 2014 413
Cell Source's Megadose Drug Combination Receives Regulatory Approval in Italy to Commence Human Clinical Trials. Nov 13, 2014 882
U.S. FDA Approves Supplemental New Drug Applications for Once-Monthly Long-Acting Therapy INVEGA SUSTENNA (paliperidone palmitate) for the Treatment of Schizoaffective Disorder. Nov 13, 2014 2631
Par Pharmaceutical Announces First FDA Approval of Vasostrict(TM) (vasopressin injection, USP). Nov 12, 2014 363
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Aeterna Zentaris Inc. (AEZS) To Contact The Firm. Nov 11, 2014 429
Endo Receives Final Approval for Generic Version of Valcyte. Nov 10, 2014 501
Endo Receives Final Approval for Generic Version of Valcyte. Nov 10, 2014 507
Providing of Pharmaceutical products. Nov 8, 2014 529
Providing of Pharmaceutical products. Nov 8, 2014 518
Switzerland : Novartis announces outcome of FDA advisory committee meeting for multiple myeloma investigational compound LBH589. Nov 7, 2014 212
FDA Issues Complete Response Letter for Aeterna Zentaris' Macrilen[TM] NDA in Adult Growth Hormone Deficiency. Nov 6, 2014 905
Glenmark Generics Receives Final ANDA Approval for Omeprazole DR Capsules. Nov 5, 2014 306
Glenmark Generics Receives Final ANDA Approval for Omeprazole DR Capsules. Nov 5, 2014 312
Mylan Launches Generic Loestrin 24 Fe. Nov 5, 2014 422
Ranbaxy Receives Approval From FDA To Market Fenofibrate Capsules USP, 43 mg And 130 mg. Nov 5, 2014 613
Lilly's CYRAMZA (ramucirumab) in Combination with Paclitaxel Granted FDA Approval for Advanced Gastric Cancer After Prior Chemotherapy. Nov 5, 2014 3858
OLYSIO (simeprevir) Gains Additional FDA Approval as Once-Daily, All-Oral Interferon- and Ribavirin-Free Treatment Option in Combination with Sofosbuvir for Adults with Genotype 1 Chronic Hepatitis C Infection. Nov 5, 2014 3549
First FDA-Approved, Once Daily Application 5% Minoxidil Formula for Women Hits the Market. Nov 4, 2014 1095
United States : FDA approves orphan drug designation to Basilea's Isavuconazole. Nov 4, 2014 134
BioDelivery Sciences Announces the Availability of BUNAVAIL(TM) in the U.S. Nov 3, 2014 2297
FDA Grants Orphan Drug Designation to Astellas for Isavuconazole for the Treatment of Invasive Candidiasis. Nov 3, 2014 734
Taiwan Province of China,United States : US FDA gives approval to TWi Pharmaceuticals on ANDA. Nov 3, 2014 106
FDA panel supports retaining warning label on Chantix. Mechcatie, Elizabeth Nov 1, 2014 456
FDA approves combination pill for hepatitis C. Boschert, Sherry Nov 1, 2014 507
Veloxis announces tentative approval of Envarsus XR. Oct 31, 2014 358
TWi Pharmaceuticals Receives US FDA Approval on Generic Donepezil Hydrochloride Tablets USP, 23 mg, its fifth ANDA from US FDA. Oct 30, 2014 276
Omidria(TM) Granted Pass-Through Reimbursement Status from CMS. Oct 30, 2014 1049
TNI BioTech, Inc., through its wholly owned subsidiary TNI BioTech International Ltd., announces start of a bridging trial in Nigeria for HIV/AIDS. Oct 30, 2014 1018
HEMACORD, the First FDA-Licensed Stem Cell Product, Wins Prix Galien USA "Best Biotechnology Product" Award. Oct 30, 2014 1327
Mylan Launches Generic Viramune XR. Oct 30, 2014 420
U.S. FDA Cardiovascular and Renal Drugs Advisory Committee Makes Recommendation on Daiichi Sankyo's Once-Daily SAVAYSA(TM) (edoxaban) for the Reduction in Risk of Stroke and Systemic Embolic Events in Patients with Non-Valvular Atrial Fibrillation. Oct 30, 2014 1779
U.S. FDA Cardiovascular and Renal Drugs Advisory Committee Makes Recommendation on Daiichi Sankyo's Once-Daily SAVAYSA(TM) (edoxaban) for the Reduction in Risk of Stroke and Systemic Embolic Events in Patients with Non-Valvular Atrial Fibrillation. Oct 30, 2014 1776
United States : First vaccine approved by FDA to prevent serogroup B Meningococcal disease. Oct 30, 2014 441
U.S. Surgical Hemostat, Internal Tissue Sealant and Adhesion Barrier Market to Reach Nearly $2.9 Billion. Oct 29, 2014 620
The National Meningitis Association Applauds FDA Approval of First Serogroup B Meningococcal Disease Vaccine. Oct 29, 2014 471
United States : FDA approves new treatment for rare form of hemophilia. Oct 25, 2014 420
More Than 80 Experts In Male Sexual Health Pen Letter To FDA Urging Approval Of Treatment Options For Female Sexual Dysfunction. Oct 23, 2014 872
CANDA NK-2 Files Motion to Dismiss Patent Infringement Suit. Oct 22, 2014 404
Boston Scientific Receives FDA And CE Mark Approval For New CoverEdge(TM) Surgical Leads For The Precision Spectra(TM) Spinal Cord Stimulator (SCS) System. Oct 21, 2014 1283
Switzerland : Novartis announces FDA Advisory Committee unanimously recommends approval of AIN457 (secukinumab) for patients with moderate-to-severe plaque psoriasis. Oct 21, 2014 437
Takeda and Orexigen Announce Availability of CONTRAVE (naltrexone HCI and bupropion HCI) Extended-Release Tablets for Chronic Weight Management in Obese Adults. Oct 20, 2014 2769
Pharmacyclics Files Supplemental New Drug Application for IMBRUVICA for Waldenstrom's Macroglobulinemia. Oct 20, 2014 2029
Halozyme Receives FDA Approval For Additional Manufacturing Facilities For Hylenex Recombinant. Oct 20, 2014 981
Eisai Announces FDA Acceptance of Supplemental New Drug Application for Antiepileptic Drug Perampanel as Adjunctive Treatment of Primary Generalized Tonic-Clonic Seizures. Oct 20, 2014 1998
Oman's Council of Ministers discuss key issues. Oct 19, 2014 1354
United States : FDA approves labeling with abuse-deterrent features for third extended-release opioid analgesic. Oct 18, 2014 453
European Commission Approves IMBRUVICA(TM) in Two Forms of Blood Cancer. Oct 17, 2014 3143
European Commission Approves IMBRUVICA(TM) in Two Forms of Blood Cancer. Oct 17, 2014 3142
Actavis Confirms Generic Quillivant XR Patent Challenge. Oct 16, 2014 896
Esbriet (pirfenidone) receives FDA approval under 'breakthrough status'; Diplomat to distribute. Oct 16, 2014 579
Pulmonary Fibrosis Foundation Applauds The Food And Drug Administration's (FDA) Prompt Decision To Approve Esbriet (pirfenidone) And OFEV (nintedanib) For The Treatment Of Idiopathic Pulmonary Fibrosis. Oct 16, 2014 909
United States : Federal judge approves FDA consent decree with Ascend Laboratories. Oct 16, 2014 344
United States : FDA approves Ofev to treat idiopathic pulmonary fibrosis. Oct 16, 2014 362
United States : FDA approves Esbriet to treat idiopathic pulmonary fibrosis. Oct 16, 2014 363
U.S. FDA Grants Priority Review Status to NDA for Anticancer Agent Lenvatinib. Oct 15, 2014 1182
FDA Approves Boehringer Ingelheim's OFEV (nintedanib) as First Kinase Inhibitor to Treat Idiopathic Pulmonary Fibrosis. Oct 15, 2014 2956
What matters: license to slip up? Ebbert, Jon O. Oct 15, 2014 393
Breckenridge Pharmaceutical, Inc. Announces Approval of Mefenamic Acid Capsules, USP 250mg. Oct 14, 2014 279
U.S. FDA Approves Antiemetic Agent Akynzeo For Prevention Of Chemotherapy-Induced Nausea and Vomiting (CINV). Oct 14, 2014 882
Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel. Oct 14, 2014 687
Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel. Oct 14, 2014 693
United Kingdom : EUROPEAN COMMISSION approves KLESCH GROUP to buy UK refinery. Oct 14, 2014 144
FDA Approves AKYNZEO (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV). Oct 13, 2014 1953
FDA Approves AKYNZEO (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV). Oct 13, 2014 2136
Presentation of Clinical Data, FDA Approval, Notes Offering, and Market Activity - Research Reports on Biogen Idec, Arrowhead, Salix, HCA and Shire. Oct 13, 2014 1623
FDA Approves AKYNZEO (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV). Oct 13, 2014 1959
FDA approves $1,125 Hepatitis C Pill: FDA. Oct 11, 2014 360
Health ministry approves use of 62 new drugs. Oct 11, 2014 317
United States : FDA approves first combination pill to treat hepatitis C. Oct 11, 2014 453
United States : FDA approves a new ultrasound imaging agent. Oct 11, 2014 375
United States : FDA approves Akynzeo for nausea and vomiting associated with cancer chemotherapy. Oct 11, 2014 387
Prime Therapeutics responds to FDA approval of Gilead's latest Hepatitis C drug. Oct 10, 2014 991
Branding Campaign, Asset Sale, Executive Promotion, Clinical Data Presentation, and Drug Approval Update - Research Reports on Synchrony Financial, Avalonbay, Aflac, Teva and AstraZeneca. Oct 7, 2014 1660
Ferring Pharmaceuticals Inc. Receives FDA Approval For New Cranberry Flavor Of PREPOPIK (Sodium Picosulfate, Magnesium Oxide, And Anhydrous Citric Acid). Oct 7, 2014 1001
HighTimes.com Features Weedhire.com Cannabis Job of the Month: October. Oct 6, 2014 599
Mylan Launches Generic Combivir. Oct 6, 2014 444
AbbVie's HUMIRA (adalimumab) Receives U.S. FDA Approval for Extension of Polyarticular Juvenile Idiopathic Arthritis Indication to Patients Ages 2 and Older. Oct 6, 2014 1551
EYLEA (aflibercept) Injection Receives FDA Approval for Macular Edema Following Retinal Vein Occlusion (RVO). Oct 6, 2014 2030
BioDelivery Sciences to Provide BUNAVAIL Launch Update. Oct 6, 2014 1609
B. Braun Receives FDA Approval For New Large-Volume Injection Containers. Oct 2, 2014 738
The Majority of Surveyed Nephrologists Do Not Differentiate Among Oral HIF-PH Inhibitors in Late Stage Clinical Development. Oct 2, 2014 772
Drug quality and security act: how it's changing the practice of pharmacy and medicine. McGuff, Ronald M. Oct 1, 2014 4374
Syncope secondary to second-degree atrioventricular block with donepezil use. Hundae, Aneley; Afzal, Aasim; Assar, Manish D.; Schussler, Jeffrey M. Report Oct 1, 2014 713
United Kingdom : Hikma receives approval for colchicine 0.6mg capsules. Oct 1, 2014 138
FDA panel backs diabetes drug liraglutide for weight loss. Ault, Alicia Oct 1, 2014 891
Par Pharmaceutical Begins Shipment of Generic Exforge. Sep 30, 2014 354
Alimera Sciences Receives $25 Million Advance from Hercules Technology Growth Capital. Sep 30, 2014 565
Israel,United States : TEVA boosts its share price on the TASE. Sep 30, 2014 368
XTANDI (enzalutamide) receives expanded approval from FDA for treatment of metastatic castration-resistant prostate cancer. Sep 30, 2014 473
Guerbet Receives FDA's Drug Shortage Assistance Award: Recognized for contributions to address a shortage of Ethiodol (ethiodized oil) injection. Sep 29, 2014 602
Switzerland : Novartis drug Signifor LAR recommended by CHMP for EU approval to treat patients with rare hormonal disorder acromegaly. Sep 29, 2014 446
New Jersey Health Foundation Awards Grant to Enhance Drug Discovery at Rutgers University. Sep 26, 2014 573
AbbVie's HUMIRA (adalimumab) Receives U.S. FDA Approval for the Treatment of Pediatric Patients with Moderately to Severely Active Crohn's Disease. Sep 25, 2014 1918
Boehringer Ingelheim Announces FDA Approval of Spiriva Respimat (tiotropium bromide) Inhalation Spray for the Maintenance Treatment of COPD. Sep 25, 2014 1842
Diclegis for Morning Sickness Now Available Through California and Nebraska Fee-For-Service Medicaid Programs. Medical condition overview Sep 23, 2014 1480
Galmed Pharmaceuticals Announces U.S. FDA Approval of Fast Track Designation of Aramchol for the Treatment of NASH. Sep 23, 2014 676
The crime of being in charge: executive culpability and collateral consequences. Copeland, Katrice Bridges Sep 22, 2014 19549
Is state 'right to try' legislation misguided policy? Hemphill, Thomas A. Sep 22, 2014 1229
Beyond Preventing Unplanned Pregnancy: The Broader Benefits of Publicly Funded Family Planning Services. Sonfield, Adam Sep 22, 2014 3254

Terms of use | Copyright © 2015 Farlex, Inc. | Feedback | For webmasters